Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not sure about the $1 mark for FEMY but with no news, it will get weaker.
Chart and 20% loss from here viable.
mb
FEMY fell to the 1.30's and some 1.20s. Despite any green showing, I would suspect that it eventually trades in the 1.20's or possibly lower.
Still jittery.
mb
Suspended until 2024
Back to $1.00 looks like
-16% great call & pumping seko ! Keep up the good work
When are you going to buy
Chart looks horrible -5% premarket selloff imminent
Femy -6% selling off people unloading there shares
Femy dumping ! Yikes
Dilution incoming -> We have entered into an Equity Distribution Agreement, dated July 1, 2022 (the “Equity Distribution Agreement”), with Piper Sandler & Co. (“Piper Sandler” or the “Sales Agent”) relating to shares of our common stock offered by this prospectus. In accordance with the terms of the Equity Distribution Agreement, under this prospectus, we may offer and sell shares of our common stock having an aggregate offering price of up to $16.7 million from time to time through the Sales Agent
the chart looks good. Today is the first green day again after a few days of consolidation. the next move could take it above the last high at 4.75. Maybe even up to $10. we will see
FEMY could see the 1.50s as the sellers keep showing up.
FEMY was 2.90 in premarket this week. My target is still $3. My avg is 2.125. Buying more this morning.
$FEMY
I don’t think this is done one bit just had its retrace by the looks of it :) adding now
Totally TRUE.....
What an Epic Pump N Dump
Company/Stock = GARBAGE. Shorts own this POS. Going NOWHERE FAST.
Early Barchart Top 100, quote delayed real time at 9:45
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
Almost got there. 2.6973. Come on lets get over 3.
$FEMY
Lets go FEMY!! I'd like to see a 3 dollar afternoon.
$FEMY
FEMY$$$$$
Bought 1.90s this morning...
GhosT
Cannot hold share price from dramatic swings = GARBAGE MANAGEMENT. NOT worth investing in this company.
The market IS NOT believing the hype. This stock is trading like an OTC stock. Management needs to learn how to market.
Any.way to, cut -it , 2-PR's-..DD_Is-''FDA's..approv'''Safe''tube-contraception-worldwide+-sales..as said by CEO to add planned sales here and in intl marketing.
Point to Document is basicly shown as
Fda approval. .As investors get the .first heads up and jumping up the target to $13
..
With today's news in PR about meeting the current audited intl , standards iin mfg to market thru the involved international markets
..with a take away being this approval is after inspection by audit.
..
Add the jump in current Target price to 13 $
and that may be a conservative view as sales numbers can not be known as time .. is needed
to watch the numbers going foward.. we will see
Tommorow is a big day. 5$ will go to ?? 3 or will they let it run with goos news before they start...
– Femasys demonstrates compliance with harmonized regulatory requirements for Australia, Brazil, Japan, Canada and the USA –
– Femasys(FEMY) is committed to bringing innovative solutions to women around the world –
ATLANTA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Femasys Inc.(FEMY) , a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced that it has successfully completed the annual Medical Device Single Audit Program (MDSAP) surveillance audit with no non-conformances and no findings.
Femasys (FEMY) currently holds Certificates of Registration for MDSAP from TUV SUD America Inc., a recognized Auditing Organization and Notified Body that conducts a single regulatory audit of medical device manufacturers that satisfies the relevant harmonized regulatory requirements for the countries participating in the MDSAP program, and ISO 13485 Quality System Certification for the commercialization of Femasys(FEMY) products in the U.S., Canada and Japan with the ability to register for market authorization in Australia and Brazil.
“Completion of the MDSAP annual surveillance audit with no non-conformances and no findings demonstrates the robustness of the Femasys Quality System and our continued commitment to compliance that extends to all of our in-house manufacturing capabilities,” said Kathy Lee-Sepsick, founder, president and chief executive officer of Femasys(FEMY). “We look forward to continuing to advance our much-needed innovative technologies in the U.S., as well as other countries around the world, via the MDSAP program."
Femasys (FEMY) is creating accessible innovative options for women, as exemplified by its lead product candidate, FemBloc® in late-stage clinical development for permanent birth control and its now-United States Food and Drug Administration (FDA)-cleared product, FemaSeed® for infertility treatment (also approved in Canada). The Company is commercializing complementary diagnostic products that were internally developed through its in-house manufacturing capabilities, with regulatory approvals in the U.S., Canada and other ex-U.S. territories.
$FEMY
It was too late to change the error ran out of posts
What short Squeeze???? 1% short.!!!
#FEMY 🔥 short squeeze! Nice set up this week! $FEMY
Ask Jesus he would tell you
Followers
|
16
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
423
|
Created
|
07/06/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |